MTND1P2

Across TCGA pan-cancer cohorts, MTND1P2 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated MTND1P2 data layer.

The strongest signal is observed in lymphoid neoplasm diffuse large b-cell lymphoma (DLBC), where higher MTND1P2 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MTND1P2 expression acts as an unfavorable survival marker, although some lineages such as BLCA and LUSC show a favorable association.

DLBC, COAD, and BLCA are the cancer types where MTND1P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
DLBC	DFS	Tertile	All	0.338	0.795	.010	49	view →
COAD	OS	Tertile	IV	0.227	0.690	<.001	36	view →
BLCA	DFS	Tertile	All	0.799	0.303	.032	18	view →
LGG	OS	Tertile	All	0.630	0.868	<.001	18	view →
LUSC	OS	Tertile	II,III,IV	0.675	0.356	.016	12	view →
SARC	DFS	Tertile	All	0.168	0.508	<.001	9	view →
ACC	OS	Tertile	III,IV	0.189	0.764	.004	9	view →
SKCM	DFS	Tertile	IV	0.036	0.433	<.001	9	view →
THYM	OS	Tertile	All	0.572	0.934	.012	6	view →
THCA	OS	Tertile	IV	0.589	0.887	.034	6	view →
PCPG	DFS	Tertile	All	0.734	0.922	.023	6	view →
STAD	DFS	Median	III,IV	0.486	0.696	.027	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

MTND1P2–DLBC (DFS)

Open the DLBC breakdown →